93 Late cardiac toxicity in survivors of esophageal cancer [17] Beukema JC, van Luijk P, Widder J, Langendijk J a., Muijs CT. Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer? Radiother Oncol 2015;114:85–90. https://doi. org/10.1016/j.radonc.2014.11.037. [18] Konski A, Li T, Christensen M, Cheng JD, Yu JQ, Crawford K, et al. Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer. Radiother Oncol 2012;104:72–7. https://doi.org/10.1016/j.radonc.2012.04.016. [19] Beukema JC, Kawaguchi Y, Sijtsema NM, Zhai TT, Langendijk JA, van Dijk L V., et al. Can we safely reduce the radiation dose to the heart while compromising the dose to the lungs in oesophageal cancer patients? Radiother Oncol 2020;149:222–7. https://doi.org/10.1016/j.radonc.2020.05.033. [20]Enright PL, McBurnie MA, Bittner V, Tracy RP, McNamara R, Arnold A, et al. The 6-min walk test: A quick measure of functional status in elderly adults. Chest 2003;123:387–98. https://doi. org/10.1378/chest.123.2.387. [21] Society A thoracic. American Thoracic Society ATS Statement : Guidelines for the Six-Minute Walk Test. AmJRespir Crit Care Med 2002;166:111–7. https://doi.org/10.1164/rccm.166/1/111. [22]Gaggin HK, Januzzi JL. Biomarkers and diagnostics in heart failure. Biochim Biophys Acta 2013;1832:2442–50. https://doi.org/10.1016/j.bbadis.2012.12.014. [23]DeFilippi CR, De Lemos JA, Christenson RH, Gottdiener JS, Kop WJ, Zhan M, et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA - J Am Med Assoc 2010;304:2494–502. https:// doi.org/10.1001/jama.2010.1708. [24]Lang RM, Badano LP, Mor-avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults : An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging 2015. https://doi.org/10.1093/ehjci/jev014. [25]Agatston AS, Janowitz FWR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quanttification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827–32. https://doi.org/10.1016/0735-1097(90)90282-T. [26]Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2 and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imagin. J Cardiovasc Magn Reson 2017;19:1–24. https://doi.org/10.1186/s12968-017-0389-8. [27]Diao K yue, Yang Z gang, Xu H yan, Liu X, Zhang Q, Shi K, et al. Histologic validation of myocardial fibrosis measured by T1 mapping: a systematic review and meta-analysis. J Cardiovasc Magn Reson 2016;18:1–11. https://doi.org/10.1186/s12968-016-0313-7. [28]Feng M, Moran JM, Koelling T, Chughtai A, Chan JL, Freedman L, et al. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys 2011;79:10–8. https://doi.org/10.1016/j.ijrobp.2009.10.058. [29]Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized Myocardial Segmentation and Nomenclature for Tomographic Imaging of the Heart 2002:539– 42. [30]Parsai C, Ohanlon R, Prasad SK, Mohiaddin RH. Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies. J Cardiovasc Magn Reson 2012;14:1. https://doi.org/10.1186/1532-429X-14-54. [31] de Groot C, Beukema JC, Langendijk JA, van der Laan HP, van Luijk P, van Melle JP, et al. RadiationInduced Myocardial Fibrosis in Long-Term Esophageal Cancer Survivors. Int J Radiat Oncol Biol Phys 2021. https://doi.org/10.1016/j.ijrobp.2021.02.007. [32]Bosch DJ, Muijs CT, Mul VEM, Beukema JC, Hospers GAP, Burgerhof JGM, et al. Impact of neoadjuvant chemoradiotherapy on postoperative course after curative-intent transthoracic esophagectomy in esophageal cancer patients. Ann Surg Oncol 2014;21. https://doi.org/10.1245/ s10434-013-3316-8. 6
RkJQdWJsaXNoZXIy MTk4NDMw